hypersensitivity to any ingredient of the investigational drug or a history of allergic reactions
multivariable analysis of the significance of GLP-1R expression was conducted by logistic regression
After 12 months of treatment, a significant improvement in FG, FI, HOMA-, and ISI were found in patients who were administered high-dose CAB whereas no significant change was found in those undergone pituitary surgery despite a greater degree of PRL reduction after the latter treatment, thus suggesting that the gluco-insulinemic metabolic improvement is mainly ascribable to CAB direct effect rather than the entity of PRL variation
Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, especially at higher doses, longer use, and when used for weight loss
Online consultation From the comfort of your home, no in-person appointments needed
And most of them are completely useless